semaglutide to tirzepatide Switching Early Dose Escalation of Tirzepatide

GLP-1 specifically binds to the glucagon-like peptide-1 receptor (GLP-1R) in the body, directly stimulating the secretion of insulin by pancreatic -cells, promoting proliferation and differentiation, and inhibiting cell apoptosis, thereby exerting a glycemic lowering effect

This includes Wegovy, Zepbound, and Saxenda when prescribed for obesity

However, the goal of these therapeutic tools is always the same: to increase the level of red blood cells as well as oxygen in your blood so that it can be efficiently distributed throughout your body and reach every organ, optimizing its function

The timing of introducing these agents, whether during active treatment or in the survivorship phase, remains undetermined

GLP1 Tracker simplifies the process of logging your weekly GLP-1 injections